Vergoeding 2016-2020 voor ATC-subgroep N02CC : Selectieve serotonine-agonisten
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| N02CC01 Sumatriptan (Imigran ®) | 12.950.900 | 11.977.700 | 12.144.800 | 12.610.600 | 11.899.300 |
| N02CC02 Naratriptan (Naramig ®) | 178.780 | 175.840 | 171.820 | 164.950 | 148.440 |
| N02CC03 Zolmitriptan (Zomig zip ®) | 254.980 | 249.420 | 277.530 | 427.370 | 367.590 |
| N02CC04 Rizatriptan (Maxalt ®) | 1.680.400 | 1.554.400 | 1.633.200 | 1.522.600 | 1.566.500 |
| N02CC05 Almotriptan (Almogran ®) | 447.980 | 419.200 | 398.760 | 387.690 | 320.330 |
| N02CC06 Eletriptan (Relpax ®) | 1.928.500 | 1.912.200 | 1.920.000 | 1.884.200 | 1.589.800 |
| N02CC07 Frovatriptan (Fromirex ®) | 1.032.100 | 709.130 | 717.840 | 887.860 | 735.330 |
| Totaal | 18.473.640 | 16.997.890 | 17.263.950 | 17.885.270 | 16.627.290 |